{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:31:44Z","timestamp":1783495904486,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41390-022-02109-5","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T12:04:25Z","timestamp":1655553865000},"page":"520-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease"],"prefix":"10.1038","volume":"93","author":[{"given":"Caterina","family":"Strisciuglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Creoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erasmo","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Paino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"2109_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/nmo.12329","volume":"26","author":"Y Nasser","year":"2014","unstructured":"Nasser, Y., Bashashati, M. & Andrews, C. N. Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but Not \u201cHigher\u201d. Neurogastroenterol. Motil. 26, 447\u2013454 (2014).","journal-title":"Neurogastroenterol. Motil."},{"key":"2109_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.bjp.0707523","volume":"153","author":"AM Miller","year":"2008","unstructured":"Miller, A. M. et al. CB2 receptor-mediated migration of immune cells: it can go either way. Br. J. Pharm. 153, 299\u2013308 (2008).","journal-title":"Br. J. Pharm."},{"key":"2109_CR3","doi-asserted-by":"publisher","first-page":"e42259","DOI":"10.1371\/journal.pone.0042259","volume":"7","author":"F Rossi","year":"2012","unstructured":"Rossi, F. et al. Cannabinoid Receptor Type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease. PLoS One 7, e42259 (2012).","journal-title":"PLoS One"},{"key":"2109_CR4","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/MCG.0000000000000755","volume":"52","author":"C Strisciuglio","year":"2018","unstructured":"Strisciuglio, C. et al. Cannabinoid Receptor 2 functional variant contributes to the risk for pediatric inflammatory bowel disease. J. Clin. Gastroenterol. 52, e37\u2013e43 (2018).","journal-title":"J. Clin. Gastroenterol."},{"key":"2109_CR5","doi-asserted-by":"crossref","unstructured":"Cencioni, M. T. et al. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via Cb2 receptors. PLos One 5, e8688 (2010).","DOI":"10.1371\/journal.pone.0008688"},{"key":"2109_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","volume":"129","author":"K Wright","year":"2005","unstructured":"Wright, K. et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129, 437\u2013453 (2005).","journal-title":"Gastroenterology"},{"key":"2109_CR7","doi-asserted-by":"crossref","unstructured":"Argenziano, M. et al. The endocannabinoid system in pediatric inflammatory and immune diseases. Int. J. Mol. Sci. 20, 5875 (2019).","DOI":"10.3390\/ijms20235875"},{"key":"2109_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/BF02358624","volume":"31","author":"RP MacDermoit","year":"1996","unstructured":"MacDermoit, R. P. Alterations of the mucosal immune system in inflammatory bowel disease. J. Gastroenterol. 31, 907\u2013916 (1996).","journal-title":"J. Gastroenterol."},{"key":"2109_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1586\/17474124.2016.1145546","volume":"10","author":"MH Farzaei","year":"2016","unstructured":"Farzaei, M. H. et al. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert Rev. Gastroenterol. Hepatol. 10, 745\u2013758 (2016).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"2109_CR10","doi-asserted-by":"crossref","unstructured":"Lu, Y. et al. Toll-like receptors and inflammatory bowel disease. Front Immunol. 9, 72 (2018).","DOI":"10.3389\/fimmu.2018.00072"},{"key":"2109_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00595-005-3144-y","volume":"36","author":"Y Toiyama","year":"2006","unstructured":"Toiyama, Y. et al. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg. Today 36, 287\u2013290 (2006).","journal-title":"Surg. Today"},{"key":"2109_CR12","first-page":"728","volume":"54","author":"YY Levine","year":"2016","unstructured":"Levine, Y. Y. et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. Zhonghua Er Ke Za Zhi. 54, 728\u2013732 (2016).","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"2109_CR13","doi-asserted-by":"crossref","unstructured":"Takiishi, T., Fenero, C. I. M. & Camara, N. O. S. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers 5, e1373208 (2017).","DOI":"10.1080\/21688370.2017.1373208"},{"key":"2109_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","volume":"90","author":"I Svizenska","year":"2008","unstructured":"Svizenska, I. et al. A Cannabinoid receptor 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures-a short review. Pharm. Biochem Behav. 90, 501\u2013511 (2008).","journal-title":"Pharm. Biochem Behav."},{"key":"2109_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/acupmed-2016-011113","volume":"34","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine. Acupunct. Med. 34, 463\u2013470 (2016).","journal-title":"Acupunct. Med."},{"key":"2109_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-2999(02)02698-5","volume":"458","author":"K Ihenetu","year":"2003","unstructured":"Ihenetu, K. et al. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Eur. J. Pharmacol. 458, 207\u2013215 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"2109_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/cs0820273","volume":"82","author":"YR Mahida","year":"1992","unstructured":"Mahida, Y. R. et al. Enhanced synthesis of neutrophil-activating peptide-1\/interleukin-8 in active ulcerative colitis. Clin. Sci. (Lond.). 82, 273\u2013275 (1992).","journal-title":"Clin. Sci. (Lond.)."},{"key":"2109_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bjp.0705889","volume":"142","author":"R Mathison","year":"2004","unstructured":"Mathison, R. et al. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br. J. Pharmacol. 142, 1247\u20131254 (2004).","journal-title":"Br. J. Pharmacol."},{"key":"2109_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MIB.0000000000001004","volume":"23","author":"KL Leinwand","year":"2017","unstructured":"Leinwand, K. L., Gerich, M. E., Hoffenberg, E. J. & Collins, C. B. Manipulation of the endocannabinoid system in colitis: a comprehensive review. Inflamm. Bowel Dis. 23, 192\u2013199 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"2109_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcp.2018.07.048","volume":"157","author":"JA Uranga","year":"2018","unstructured":"Uranga, J. A. et al. Cannabinoid pharmacology and therapy in gut disorders. Biochem Pharm. 157, 134\u2013147 (2018).","journal-title":"Biochem Pharm."},{"key":"2109_CR21","doi-asserted-by":"crossref","unstructured":"Pellati, F. et al. Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. Biomed. Res. Int. 2018, 1691428 (2018).","DOI":"10.1155\/2018\/1691428"},{"key":"2109_CR22","doi-asserted-by":"crossref","unstructured":"Liao, W. et al. Chelidonine suppresses LPS-Induced production of inflammatory mediators through the inhibitory of the TLR4\/NF-\u03baB signaling pathway in RAW264.7 macrophages. Biomed. Pharmacother. 107, 1151\u20131159 (2018).","DOI":"10.1016\/j.biopha.2018.08.094"},{"key":"2109_CR23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10753-019-01008-y","volume":"42","author":"BZ Shao","year":"2019","unstructured":"Shao, B. Z. et al. Targeting Nlrp3 inflammasome in inflammatory bowel disease: putting out the fire of inflammation. Inflammation 42, 1147\u20131159 (2019).","journal-title":"Inflammation"},{"key":"2109_CR24","doi-asserted-by":"crossref","unstructured":"Suryavanshi, S. V., Kovalchuk, I. & Kovalchuk, O. Cannabinoids as key regulators of inflammasome signaling: a current perspective. Front. Immunol. 11, 613613 (2021).","DOI":"10.3389\/fimmu.2020.613613"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02109-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T15:09:20Z","timestamp":1678115360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02109-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02109-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the University \u201cVanvitelli\u201d approved the study protocol with the registration number Prot. 0013347\/i. Written informed consent was obtained from parents and approval was acquired from children before any interventions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}